Outcomes of single- and two-stage revision total knee arthroplasty for chronic periprosthetic joint infection

医学 假体周围 生存曲线 外科 队列 关节置换术 比例危险模型 内科学 回顾性队列研究 阶段(地层学) 癌症 生物 古生物学
作者
Hosam E. Matar,Benjamin V. Bloch,S. Snape,Peter James
出处
期刊:The bone & joint journal [British Editorial Society of Bone & Joint Surgery]
卷期号:103-B (8): 1373-1379 被引量:40
标识
DOI:10.1302/0301-620x.103b8.bjj-2021-0224.r1
摘要

Aims Single-stage revision total knee arthroplasty (rTKA) is gaining popularity in treating chronic periprosthetic joint infections (PJIs). We have introduced this approach to our clinical practice and sought to evaluate rates of reinfection and re-revision, along with predictors of failure of both single- and two-stage rTKA for chronic PJI. Methods A retrospective comparative cohort study of all rTKAs for chronic PJI between 1 April 2003 and 31 December 2018 was undertaken using prospective databases. Patients with acute infections were excluded; rTKAs were classified as single-stage, stage 1, or stage 2 of two-stage revision. The primary outcome measure was failure to eradicate or recurrent infection. Variables evaluated for failure by regression analysis included age, BMI, American Society of Anesthesiologists grade, infecting organisms, and the presence of a sinus. Patient survivorship was also compared between the groups. Results A total of 292 consecutive first-time rTKAs for chronic PJI were included: 82 single-stage (28.1%); and 210 two-stage (71.9%) revisions. The mean age was 71 years (27 to 90), with 165 females (57.4%), and a mean BMI of 30.9 kg/m 2 (20 to 53). Significantly more patients with a known infecting organism were in the single-stage group (93.9% vs 80.47%; p = 0.004). The infecting organism was identified preoperatively in 246 cases (84.2%). At a mean follow-up of 6.3 years (2.0 to 17.6), the failure rate was 6.1% in the single-stage, and 12% in the two-stage groups. All failures occurred within four years of treatment. The presence of a sinus was an independent risk factor for failure (odds ratio (OR) 4.97; 95% confidence interval (CI) 1.593 to 15.505; p = 0.006), as well as age > 80 years (OR 5.962; 95% CI 1.156 to 30.73; p = 0.033). The ten-year patient survivorship rate was 72% in the single-stage group compared with 70.5% in the two-stage group. This difference was not significant (p = 0.517). Conclusion Single-stage rTKA is an effective strategy with a high success rate comparable to two-stage approach in appropriately selected patients. Cite this article: Bone Joint J 2021;103-B(8):1373–1379.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wcj发布了新的文献求助10
刚刚
www完成签到,获得积分10
1秒前
ZXY完成签到 ,获得积分10
1秒前
1秒前
1111完成签到 ,获得积分10
2秒前
充电宝应助小底采纳,获得10
2秒前
华仔应助顺利秋灵采纳,获得10
2秒前
琦琦完成签到 ,获得积分10
2秒前
2秒前
2秒前
深情安青应助伊凡采纳,获得10
2秒前
Chaimengdi发布了新的文献求助10
3秒前
小乌龟完成签到,获得积分10
3秒前
3秒前
3秒前
鸣笛应助彩色垣采纳,获得10
3秒前
4秒前
4秒前
4秒前
4秒前
天天天晴完成签到,获得积分10
5秒前
积极的誉完成签到,获得积分10
5秒前
我要学习发布了新的文献求助10
5秒前
5秒前
wcj完成签到,获得积分20
6秒前
6秒前
zxm完成签到,获得积分10
6秒前
ZSFL发布了新的文献求助10
6秒前
Thea完成签到 ,获得积分10
6秒前
眼睛大的薯片完成签到,获得积分10
7秒前
7秒前
KATHY完成签到,获得积分20
8秒前
棋士应助爱笑煎蛋采纳,获得10
8秒前
kkkkkk发布了新的文献求助10
8秒前
yyyyyy完成签到,获得积分10
8秒前
unique发布了新的文献求助10
8秒前
UU发布了新的文献求助10
9秒前
9秒前
10秒前
10秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
Residual Stress Measurement by X-Ray Diffraction, 2003 Edition HS-784/2003 588
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3950593
求助须知:如何正确求助?哪些是违规求助? 3495971
关于积分的说明 11080135
捐赠科研通 3226361
什么是DOI,文献DOI怎么找? 1783812
邀请新用户注册赠送积分活动 867916
科研通“疑难数据库(出版商)”最低求助积分说明 800977